help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 56, No. 6 1316-1318
doi:10.1210/jcem-56-6-1316
Copyright © 1983 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koulu, M.
Right arrow Articles by Huupponen, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koulu, M.
Right arrow Articles by Huupponen, R.

Effect of the Benzodiazepine Derivative, Diazepam, on the Clonidine-Stimulated Human Growth Hormone Secretion

Markku Koulu, Kalevi Pihlajamaki and Risto Huupponen

Department of Pharmacology, Institute of Biomedicine, University of Turku, Turku, Finland

Address requests for reprints to: Dr. Markku Koulu, Department of Pharmacology, Institute of Biomedicine, University of Turku, Turku, Finland.

{gamma}-Aminobutyric acid (GABA) has both stimulatory and inhibitory effect on human GH secretion. We previously reported that the benzodiazepine derivative diazepam, which exerts its main pharmacological effect by facilitating GABA-mediated transmission, is able to reduce the GH response to L-dopa and apomorphine. To establish whether diazepam affects the {alpha}-adrenergic regulation of GH secretion, the GH response to clonidine (an {alpha}-agonist) was investigated in seven volunteers after placebo and diazepam premedications.

After placebo pretreatment, clonidine (0.15 mg iv infused over 20 min) significantly stimulated GH secretion: the mean serum GH level rose from a basal level of 4.7 ± 1.1 (±SEM) ng/ml to a maximum of 10.8 ± 1.6 ng/ml (P < 0.025). After 3 days of diazepam treatment, a similar GH response to clonidine was observed; the mean serum GH level rose from a basal value of 2.3 ± 0.3 ng/ml to a maximum of 9.4 ±1.3 ng/ml.

It is concluded that the inhibitory effect of diazepam on human GH secretion is mediated via inhibition of dopaminergic transmission, whereas the {alpha}-adrenergic control of GH release is not affected. Since diazepam potentiates GABAergic transmission, its effect may reflect the role of endogenous GABA in human GH secretion. (J Clin Endocrinol Metab 56: 1316,1983)

Received October 14, 1982.




This article has been cited by other articles:


Home page
J PsychopharmacolHome page
P. Glue, D. Nutt, and P. Glue
Clonidine challenge testing of alpha-2-adrenoceptor function in man: the effects of mental illness and psychotropic medication
J Psychopharmacol, January 1, 1988; 2(3-4): 119 - 137.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1983 by The Endocrine Society